Cargando…
MiR-629 promotes human pancreatic cancer progression by targeting FOXO3
The FOXO signaling pathway has been reported to have an important role in human cancer. Expression of miR-629 was markedly upregulated in pancreatic cancer and negatively correlated with FOXO3. Therefore, exploring the regulatory mechanism of miR-629 and FOXO3 signaling may provide valuable clinical...
Autores principales: | Yan, Haijiao, Li, Qing, Wu, Jun, Hu, Wenwei, Jiang, Jingting, Shi, Liangrong, Yang, Xin, Zhu, Danxia, Ji, Mei, Wu, Changping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682687/ https://www.ncbi.nlm.nih.gov/pubmed/29072689 http://dx.doi.org/10.1038/cddis.2017.525 |
Ejemplares similares
-
miR-629 targets FOXO3 to promote cell apoptosis in gastric cancer
por: Li, Ming, et al.
Publicado: (2020) -
MiR‐629 regulates hypoxic pulmonary vascular remodelling by targeting FOXO3 and PERP
por: Zhao, Mei, et al.
Publicado: (2019) -
Prognostic Significance of miR-181b and miR-21 in Gastric Cancer Patients Treated with S-1/Oxaliplatin or Doxifluridine/Oxaliplatin
por: Jiang, Jingting, et al.
Publicado: (2011) -
MiR-629-5p promotes colorectal cancer progression through targetting CXXC finger protein 4
por: Lu, Jinlai, et al.
Publicado: (2018) -
MiR-629-5p Promotes Prostate Cancer Development and Metastasis by Targeting AKAP13
por: Liu, Yangzhou, et al.
Publicado: (2021)